Marksans acquired Relonchem

 

Marksans Pharmaceutical Limited, one of India’s leading mid-size pharmaceutical company, announced the acquisition of Relonchem Limited, a leading UK based generic pharmaceutical company for an undisclosed sum. Relonchem Limited has clocked sales of US $ 32 million (approx.)

 

The recent acquisition will give Marksans Pharma an immediate sales and marketing front-end access to the highly regulated and lucrative generic medicines market in UK and Europe. The Company expects to derive significant cost benefits by transferring Relonchem Limited’s manufacturing operations to its state-of-the-art India manufacturing facilities.